View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Theme
  2. Macro
  3. Covid-19
May 21, 2020

Moderna’s Covid-19 vaccine looks to gain first approval

By Victoria Smith

In mid-May, Moderna Therapeutics’ Covid-19 vaccine candidate, mRNA-1273, received Fast Track designation from the Food and Drug Administration (FDA). The FDA also approved Moderna to begin a Phase II clinical trial study a few days before the approval.

Fast Track designation, as well as the initiation of the Phase II trial, could mean mRNA-1273 is the first vaccine to be approved and launched for the Covid-19 pandemic. Read more here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena